Search   
MSDS  : Glutamic acid, N-(p-(((2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridi nyl)methyl)amino) benzoyl)-, L-
CAS  : 135-16-0
SYNONYMS  : * Tetrahydrofolic acid * 5,6,7,8-Tetrahydrofolic acid * Tetrahydropteroylglutamic acid
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : MA0600800
CHEMICAL NAME : Glutamic acid,
N-(p-(((2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridi
nyl)methyl)amino) benzoyl)-, L-
CAS REGISTRY NUMBER : 135-16-0
LAST UPDATED : 199707
DATA ITEMS CITED : 5
MOLECULAR FORMULA : C19-H23-N7-O6
MOLECULAR WEIGHT : 445.49
COMPOUND DESCRIPTOR : Reproductive Effector
SYNONYMS/TRADE NAMES :
* Tetrahydrofolic acid
* 5,6,7,8-Tetrahydrofolic acid
* Tetrahydropteroylglutamic acid

*** HEALTH HAZARD DATA ***

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 18 gm/kg/5W-I
TOXIC EFFECTS :
Liver - changes in liver weight
Kidney, Ureter, Bladder - changes in bladder weight
Blood - normocytic anemia
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1104,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 6 gm/kg/6D-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
acute tubular necrosis)
Kidney, Ureter, Bladder - changes in bladder weight
Related to Chronic Data - death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1128,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 46800 mg/kg/26W-I
TOXIC EFFECTS :
Liver - changes in liver weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1114,1973

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE : 70 mg/kg
SEX/DURATION : female 8-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - physical
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1132,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE : 70 mg/kg
SEX/DURATION : female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in
number of implants per female; total number of implants per corpora lutea)
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 7,1132,1973

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Glucosylamine, N-(6-butoxy-3-pyridyl)- 554-18-7
beta-D-Glucosylamine, N-methyl-N-nitroso- 31364-55-3
alpha-D-Glucopyranoside,beta-D-fructofuranosyl-O-alpha-D-galactopyranosyl-(1-6)-, hexadecanoate 31364-55-3
Glucothiose 31364-55-3
Glucuronamide 3789-97-7
D-Glucuronamide, N-(4-(aminosulfonyl)phenyl)- 3789-97-7
Glucuronic acid, O-(4-biphenylylamino)- 3789-97-7
Glucuronic acid, O-(2-fluorenylamino)- 3789-97-7
Glucuronic acid, gamma-lactone, D- 32449-92-6
Glucuronic acid, gamma-lactone,1-(isonicotinoylhydrazone), D- 3691-74-5
D-Glucuronic acid, compd. with5-methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-2,4- quinazolinediamine (1:1) 82952-64-5
Glucuronic acid, monosodium salt 7182-77-6
Glucuronidase, beta- 9001-45-0
alpha-D-Glucopyranoside,beta-D-fructofuranosyl-O-alpha-D-galactopyranosyl-(1-6)-, octadecanoate 9001-45-0
Glutaconic acid, 3-hydroxy-, dimethyl ester, diethylphosphate 50708-20-8
Glutaconic acid, 3-hydroxy-, dimethyl ester, dimethylphosphate 122-10-1
Glutaconic acid, 3-hydroxy-, dimethyl ester, dimethylphosphate, (E)- 15272-77-2
Glutaconic acid, 3-hydroxy-, dimethyl ester, dimethylphosphate, (Z)- 15272-78-3
Glutaconic acid, 3-hydroxy-, dimethyl ester, O-esterwith O,O-dimethylphosphorothioate, (E)- 21395-86-8
Glutaconimide, 2-amino-4-ethyl-4-phenyl- 14387-60-1
Glutaconimide, 4-ethyl-2-hydroxy-4-phenyl- 14387-62-3
Glutaconimide, 4-ethyl-2-methoxy-N-methyl-4-phenyl- 56392-81-5
L-Glutamamide,L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl-N-(((1-carboxy-3-methylbutyl) amino)carbonyl)glycyl-N(sup1)-(1-methyl-2-oxoethyl)-, stereoisomer 51798-45-9
L-Glutamamide, N(sup2)-(3-hydroxy-1-oxododecyl)-L-asparaginyl-N(sup1)-(1-(dimethoxymethyl)- 3-methylbutyl)- 125850-33-1
alpha-D-Glucopyranoside,beta-D-fructofuranosyl-O-alpha-D-galactopyranosyl-(1-6)-, (Z)-9-octadecenoate 96352-58-8
L-Glutamamide, N(sup2)-(3-hydroxy-1-oxododecyl)-L-asparaginyl-N(sup1)-(1-formyl-3- methylbutyl)- 125882-62-4
Glutamic acid, DL- 617-65-2
Glutamic acid, L- 56-86-0
L-Glutamic acid, N-acetyl- 1188-37-0
L-Glutamic acid,N-(3-(2-(4-(acetylamino)-1-oxobutyl)-5-chlorophenyl)-1-oxopropyl)-, diethyl ester 122186-90-7
Glycine,N-(3-(2-(4-(acetylamino)-1-oxobutyl)-5-chlorophenyl)-1-oxopropyl)-, ethyl ester 122186-87-2
DL-Glutamic acid, N-acetyl-,bis(2-(dimethoxyphosphinyl)ethyl)ester 152819-37-9
Glycine,N-((2-acetyl-7-butoxy-4-benzofuranyl)sulfonyl)-N-methyl- 105642-02-2
Glycine,N-((2-acetyl-7-((4-chlorophenyl)methoxy)-4-benzofuranyl)sulfonyl)-N-((4- chlorophenyl)methyl)- 105627-73-4
Glutamic acid, N-acetyl-, compd. with2-(dimethylamino)ethanol (1:1), L- 3342-61-8
alpha-D-Glucopyranoside,beta-D-fructofuranosyl-O-alpha-D-galactopyranosyl-(1-6)-, tetradecanoate 3342-61-8
Glutamic acid, N-acetyl-, compd. with2-(dimethylamino)ethanol (1:2), L- 3342-61-8
Glutamic acid, N-acetyl-, L-, compd. with L-lysine 24577-75-1
L-Glutamic acid, N-(aminocarbonyl)- 1188-38-1
L-Glutamic acid,N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-, mixed with L-cysteine 8064-47-9
L-Glutamic acid,N-(4-(((2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl)-2-propynylamino) benzoyl)- 76849-19-9
Glutamic acid,N-(p-(((2-amino-5-formyl-5,6,7,8-tetrahydro-3-hydroxy-6-pteridinyl)methyl) amino)benzoyl)-, calcium salt(1:1), L- 1492-18-8
Glutamic acid,N-(p-(((2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino) benzoyl)-, L- 135-16-0
L-Glutamic acid,N-(N-(4-(((2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)formylamino)benzoyl)-L-gamma-glutamyl)-, hydrate(1:5) 29552-62-3
L-Glutamic acid,N-(4-(2-(2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl) ethyl)benzoyl)- 95693-76-8
Glutamic acid,N-(p-((2-(2-amino-4-hydroxy-6-pteridinyl)ethyl)amino)benzoyl)- 3566-25-4
beta-D-Glucopyranoside,1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1a-alpha,1b-beta,2-beta,5a-beta,6-beta,6a-alpha))- 6736-85-2
Glutamic acid,N-(p-((1-(2-amino-4-hydroxy-6-pteridinyl)ethyl)amino)benzoyl)- L- 2179-16-0
Glutamic acid,N-(p-(((2-amino-4-hydroxy-6-pteridyl)methyl)methylamino)benzoyl)- 2410-93-7
L-Glutamic acid,N-(1,5-anhydro-2,4-dideoxy-3-C-methyl-L-threo-pentitol-2-yl)- 134309-96-9

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net